Principle Partner

Dr. Raj Bawa is president of Bawa Biotech LLC. He is an inventor, entrepreneur, professor and a registered patent agent licensed to practice before the U.S. Patent & Trademark Office.  Trained as a biochemist and microbiologist, he has been an active researcher for the past two decades.  He has extensive expertise in pharmaceutical sciences, biotechnology, nanomedicine, drug delivery and biodefense-related scientific, FDA regulatory and patent law issues.  Since 1999, he has held various adjunct faculty positions at Rensselaer Polytechnic Institute in Troy, NY where he is currently an adjunct professor of biological sciences and where he received his Ph.D. degree (Biophysics/Biochemistry; 1987-1990).  Since 2004, he has been an adjunct associate professor of natural and applied sciences at NVCC in Annandale, VA. 
Since 2012, he has been a scientific advisor to Teva Pharmaceutical Industries, Ltd., Israel.  

He previously served as patent legal advisor at Sequoia Pharmaceuticals, Gaithersburg, MD and as senior scientist at SynerGene Therapeutics, Inc., Potomac, MD. He recently served as principal investigator of two National Cancer Institute/SBIR contracts titled “Targeted nanocomplexed iron oxide for early detection with concurrent hyperthermia treatment of cancer” and “A targeted nanocomplex for early detection of lung cancer.”  In the 1990s, Dr. Bawa held various positions at the US Patent & Trademark Office, including primary examiner (6 years) and instructor at the US Patent Academy.  He is a life member of Sigma Xi, founding director of the American Society for Nanomedicine, and co-chair of the Nanotech Committee of the American Bar Association.  He has authored over 100 publications, co-edited two texts, presented or chaired at over 200 conferences worldwide and serves on the editorial boards of 16 peer-reviewed journals.